Bortezomib inhibits the survival and proliferation of bone marrow stromal cells

BACKGROUND: Bortezomib is widely used for the treatment of multiple myeloma. Bone marrow stromal cells (BMSCs) endow myeloma cells with survival and growth advantages. However, the influence of bortezomib on BMSCs is not well elucidated. We examined the effects of bortezomib on the survival and grow...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood Res
Hoofdauteurs: Kim, Ha-Yon, Moon, Ji-Young, Ryu, Haewon, Choi, Yoon-Seok, Song, Ik-Chan, Lee, Hyo-Jin, Yun, Hwan-Jung, Kim, Samyong, Jo, Deog-Yeon
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486164/
https://ncbi.nlm.nih.gov/pubmed/26157778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.2.87
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items